SVMMARY. The lipoprotein(a) (Lp(a)) time course during and after coronary artery bypass grafting was examined in 20 caucasoid patients, in relation to the time courses of serum cholesterol and serum triglycerides. Samples were taken at eight different time points. Baseline geometric means (SD) for Lp(a), cholesterol and triglycerides were 115 (336) mg/L, 5·73 (1-10) mmol/L and 1·73 (1'21) rnmol/L, respectively. Up to 10min after cardiopulmonary bypass (CPB) and after correction for haemodilution, no observable effect of CPB on serum concentrations of Lp(a) could be demonstrated, whereas serum concentrations of total cholesterol and triglycerides showed a progressive and significant decline. Ten minutes after stopping CPB geometric means for cholesterol and triglyceride were 3·90 (0'82) and 0·90 (0'58) mrnol/L, respectively. At the third post-operative day geometric Lp(a) and cholesterol means decreased to 62 (90) mg/l, and 2·97 (0·84) mmol/L, respectively, while triglycerides went up. It is concluded that Lp(a) levels remain constant during CPB, but mimic total cholesterol changes in the post-CABG period.
INTRODUCTION
Serum lipids, lipoprotein and apolipoprotein levels are generally known to be affected by major surgery and trauma.' Whereas literature upon the time course of changes in serum lipid concentrations after coronary artery bypass grafting (CABG) is quite unanimous.? it is conflicting with respect to changes in serum lipoprotein(a) (Lp(a)),3 S adding to the reputation that Lp(a) continues to confuse and mystify. CABG surgery is special in that it involves both major surgery and the use of extracorporeal circulation and a cardiopulmonary bypass pump, which necessitates haemodilution to prime the pump. Some authors showed a profound Lp(a) decline after coronary surgery and a non-significant trend to over-shoot above baseline values at the end of the first postoperative week, followed by normalization after I month.v' In contrast, Sgoutas et al? reported that Lp(a) levels doubled within minutes of Correspondence to: Christa Cobbaert. cardiopulmonary bypass (CPB), i.e hours before any rise in C-reactive protein, and persisted at a similar level up to at least the third postoperative day. As CPB is associated with acute activation of the complement system and with changes in fibrinolytic parameters," Sgoutas suggested that Lp(a) might respond to events associated with immunological activation. Moreover, the authors hypothesized that the Lp(a) changes in the acute setting of CABG might provide a model for understanding control of its production and function.
In order to shed more light upon the validity of the published data, serum Lp(a) and serum lipid changes during and after CABG were re-examined, using multiple timed venous blood samples, standardized anaesthesia and documented cardiopulmonary bypass (CPB) procedures in all patients.
SUBJECTS AND METHODS
Twenty Caucasian men, aged 43 to 72 years, undergoing elected CABG, were included, none 
·Serum cholesterol, triglycerides and lipoprotein(a) concentrations are corrected for changes in plasma volume, whenever appropriate: plasma volume corrections were always made for the samples collected at time point 6 and 7, and for samples drawn at sample points 5 and 8. "Key to time points: I = baseline, i.e. the day before coronary surgery; 2 = before anaesthesia; 3 = after anaesthesia; 4=before heparinization; 5= 10min after heparinization; 6=20min after starting cardiopulmonary bypass; 7 = 10 min after stopping cardiopulmonary bypass; 8 = 72 h after starting cardiopulmonary bypass.
of whom had a myocardial infarction within the previous three months. All cardiac medications were continued into the peri-operative period. Venous blood was collected for haemoglobin, haematocrit, serum Lp(a) and serum lipids. Blood samples were procured the day before coronary surgery, before and after induction of anaesthesia, before and after intravenous heparin administration, and before, during and after CABG (Tables 1-3) . Before beginning CPB, lidoflazine (I mg/kg) was administrated intravenously. Anaesthesia was induced by etomidate (0' 3 mg/kg), sufentanil (SO J.lg) and a relaxant, pancuronium or vecuronium (0,1 mg/kg), and maintained by midazolam (10 mg) and supplemental sufentanil, in such a way that haemodynamic stability was preserved. Heparinization was initiated by administrating 300 IU of heparin per kg body weight. During CPB, additional heparin was sometimes given in order to maintain the activated clotting time between 400 and 600 s. In the CPB circuit different types Ann Clin Biochem 1998: 35 of membrane oxygenators (Dideco 8703, Macchi, Maxima 1300 or Scimed Ultrox) were employed. The circuit was primed with Ringer'slactate solution, containing human albumin, mannitol and heparin (5000 IU). Aorta unclamping was done intermittently. No cell-saver was used. After initiation of extracorporeal circulation patients were systematically cooled to 28°C. No patient was transfused with heterologous plasma during CPB, and no patient showed post-operative complications. Research procedures followed were in accordance with the ethical standards of the University Hospital internal review board.
Haemoglobin and haematocrit were determined in fresh EDTA blood, using standard procedures, while serum was stored at -20°C for batch Lp(a) and lipid analyses. Maximum storage time was 2 months. Serum Lp(a) concentrations were determined by ELISA (Catalogue No. 610220; Biopool AB, Umeii, Sweden). According to Biopool, the Lp(a) test Triglyceride levels (mrnol/L)
See Table I for key to footnotes. 83  120  109  156  176  194  16  2  25  24  29  28  26  21  II  3  283  343  358  289  465  392  369  112  4  911  883  1059  1043  691  692  720  186  S  8S  96  81  122  183  98  47  6  29  44  36  57  45  51  36  7  485  506  492  538  504  390  150  8  88  83  83  103  98  94  37  9  1303  1492  1138  1286  1284  1028  1066  350  10  343  557  525  641  558  604  209  II  291  279  266  289  320  191  181  101  12  97  132  87  147  134  117  68  13  13  13  15  16  18  18  20  13  14  540  535  545  524  548  459  376  237  15  III  84  74  50  104  171  171  67  16  II  37  7  14  7  9  11  47  17  24  18  17  14  17  20  14  36  18  114  85  74  92  137  143  165   44   19  133  142  249  140  205  203  190  75  20  106  124  140  107  110  111 kit utilizes sheep polyclonal antibodies against purified human Lp(a) which are adsorbed on to immobilized low-density lipoprotein (LDL) and immobilized human plasminogen, and affinity purified on immobilized Lp(a). Lp(a) is measured by using Lp(a) specific antibodies immobilized on micro-test plates as catch antibodies and Lp(a) specific antibodies conjugated to horseradish peroxidase as tag antibodies. Serum cholesterol was measured by an enzymatic CHaD-PAP method. Total serum triglycerides were measured by a GPO-PAP method, and no correction was made for free glycerol. Typical coefficients of variation (CVs) for the Lp(a), cholesterol and triglyceride assays used were 6·7%, 2·1 % and 2·8%, respectively. For each patient, samples were measured in duplicate within the same batch. Lp(a) and serum lipids concentrations were corrected for haemodilution by multiplying measured values by the ratio of baseline haematocrit to haernatocrit at the time of sampling. Corrected Lp(a) and serum lipid values were logarithmically transformed and geometric means were calculated for each sampling time. Differences between sampling points larger than three times the between-batch CV were considered significant.
RESULTS
In all subjects, haemoglobin, haematocrit, serum Lp(a) and serum lipids decreased before and during CPB (data not shown). Ten minutes after heparinization the haematocrit was on average at 92% of the average baseline value; 20 min after starting CPB the haematocrit was at 67·5% and IOmin after stopping CPB it was at 71%. After correction for haemodilution (Table I) , serum cholesterol levels still showed a linear decline across all sampling points, leading to a geometric mean cholesterol value at the third post-operative day of 2·97 mmol/L, i.e. 52% of the baseline value. Triglycerides levels also displayed a gradual decline during and immediately after stopping CPB, but were either normalized or increased above baseline at the third post-operative day ( Table 2 ). In contrast, serum Lp(a) levels did not significantly change during and up to 10min after CABG, whereas at the third post-operative day geometric mean Lp(a) was only 62 rng/L, i.e. 54% of the baseline geometric mean (Table 3 ).
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DISCUSSION
Surgery, just like infection and inflammation, stimulates cytokine production which results in marked changes in the blood concentrations of specific proteins, the so-called 'acute phase proteins'.' The acute phase response of the host to various stimuli is believed to be advantageous, acute phase proteins playing an important homeostatic role in the injured or diseased patient. To this end, C-reactive protein and complement 3, for example, help in the opsonization of bacteria, immune complexes and foreign particles. Likewise, cytokine-induced changes in serum lipid and lipoprotein levels are also considered to be opportune and part of the acute phase response. It has been documented in primates that the cytokinemediated acute phase response increases very low-density lipoprotein (VLDL), and hence serum triglyceride levels, decreases high-density lipoprotein (HDL)-and low-density lipoprotein (LDL)-cholesterol levels and increases Lp(a) levels. I The increase in serum triglycerides is believed to be beneficial as, first, elevated VLDL levels enhance delivery of lipids to cells that are involved in tissue repair and to cells that are activated during the immune response; and, secondly, represent a detoxifying mechanism by binding endotoxins and a variety of viruses. I The decrease in serum cholesterol partially results from decreased LDL production due to reduced cholesterol and apo B secretion, and increased LDL-receptor activity. The latter also reflects enhanced cholesterol delivery to cells. So far, the significance of the concomitant Lp(a) increase is incompletely understood. I
In the present study the Lp(a) time course during and after CABG was examined in relation to the time course of changes in the other serum lipids. Up to 10 min after CPS and after correction for haemodilution, no observable effect of CPB on serum concentrations of Lp(a) could be demonstrated, whereas serum concentrations of total cholesterol and triglycerides showed a progressive and significant decline. The peri-operative triglyceride decline most likely reflects increased lipoprotein lipase activity and ensuing intravascular lipolysis caused by massive heparin cofactor administration during CPB. At the third post-operative day, the acute phase response became obvious, triglyceride levels being either normalized or increased compared to baseline levels, and cholesterol levels being profoundly decreased.
Notably, Lp(a) levels were similarly decreased as serum cholesterol levels at the third postoperative day. In the case of serum lipids, our observations underscore previous work upon changes of serum lipids following major surgical operations, either without or with extracorporeal circulation and haemodilution.s? We confirm that Lp(a) mimics total cholesterol changes in the immediate post-CABG period, as evidenced by the similar per cent decrease at the third postoperative day for both parameters, confirming previous work from us] and others," but in contrast to Sgoutas' findings.' Although differences between anaesthetic agents and CPB systems employed may partially explain the dissimilarity, it is likely that basal Lp(a) levels, as measured by Sgoutas et al., have been underestimated due to the fact that baseline samples were drawn after induction of anaesthesia and prior to CABG, neglecting expansion of circulating volume, commonly practised by anaesthetists prior to coronary surgery. Hence, we hypothesize that invalid basal values formed the basis for the acute phase behaviour of Lp(a) in minutes after CBP, and for masking the Lp(a) invariability and the modest serum lipid decline during CPB. Moreover, although the Lp(a) nadir at the third post-operative day apparently conflicts with the acute phase behaviour of Lp(a), this is not the case. After all, it was previously demonstrated that the Lp(a) time course deviates from the cholesterol time course only after the third post-operative day, and displays an increase compared to baseline Lp(a) levels at the tenth post-operative day.2,] Finally, we hypothesize that one of the mechanisms responsible for reducing cholesterol levels after major surgery, i.e. diminished LDL production due to decreased cholesterol and apo B secretion, might also explain the initial decline in Lp(a) levels in the first post-operative days.'
In conclusion, the paradoxical Lp(a) increase noted in minutes after starting CPB appears to be an artefact. In our effort to unravel the role of the enigmatic Lp(a) particle we should be careful not to make the mystery deeper.
